China Recombinant Human Endostatin Market Research Report Forecast 2017 to 2022

November 2017 | 128 pages | ID: CE779477F76EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Recombinant Human Endostatin Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Recombinant Human Endostatin industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant Human Endostatin market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals

China Recombinant Human Endostatin Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Recombinant Human Endostatin Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 RECOMBINANT HUMAN ENDOSTATIN MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Market Segmentation by Type
  1.2.1 China Production Market Share of Recombinant Human Endostatin by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Recombinant Human Endostatin Market Segmentation by Application
  1.3.1 Recombinant Human Endostatin Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Recombinant Human Endostatin (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON RECOMBINANT HUMAN ENDOSTATIN INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Recombinant Human Endostatin Industry

CHAPTER 3 CHINA RECOMBINANT HUMAN ENDOSTATIN MARKET COMPETITION BY MANUFACTURERS

3.1 China Recombinant Human Endostatin Production and Share by Manufacturers (2015 and 2016)
3.2 China Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Recombinant Human Endostatin Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant Human Endostatin Market Competitive Situation and Trends
  3.5.1 Recombinant Human Endostatin Market Concentration Rate
  3.5.2 Recombinant Human Endostatin Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA RECOMBINANT HUMAN ENDOSTATIN CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Recombinant Human Endostatin Capacity, Production and Growth (2012-2017)
4.2 China Recombinant Human Endostatin Revenue and Growth (2012-2017)
4.3 China Recombinant Human Endostatin Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA RECOMBINANT HUMAN ENDOSTATIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Recombinant Human Endostatin Production and Market Share by Type (2012-2017)
5.2 China Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
5.3 China Recombinant Human Endostatin Price by Type (2012-2017)
5.4 China Recombinant Human Endostatin Production Growth by Type (2012-2017)

CHAPTER 6 CHINA RECOMBINANT HUMAN ENDOSTATIN MARKET ANALYSIS BY APPLICATION

6.1 China Recombinant Human Endostatin Consumption and Market Share by Application (2012-2017)
6.2 China Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA RECOMBINANT HUMAN ENDOSTATIN MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Biocon
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Mabtech
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Fujifilm Kyowa Kirin Biologics
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Enzon Pharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Genexine
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Hetero Drugs
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Onyx Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 RECOMBINANT HUMAN ENDOSTATIN MANUFACTURING COST ANALYSIS

8.1 Recombinant Human Endostatin Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant Human Endostatin

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Recombinant Human Endostatin Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA RECOMBINANT HUMAN ENDOSTATIN MARKET FORECAST (2017-2022)

12.1 China Recombinant Human Endostatin Production, Revenue Forecast (2017-2022)
12.2 China Recombinant Human Endostatin Production, Consumption Forecast by Regions (2017-2022)
12.3 China Recombinant Human Endostatin Production Forecast by Type (2017-2022)
12.4 China Recombinant Human Endostatin Consumption Forecast by Application (2017-2022)
12.5 Recombinant Human Endostatin Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Human Endostatin
Figure China Production Market Share of Recombinant Human Endostatin by Type in 2016
Table Recombinant Human Endostatin Consumption Market Share by Application in 2016
Figure China Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Table China Recombinant Human Endostatin Capacity of Key Manufacturers (2015 and 2016)
Table China Recombinant Human Endostatin Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Recombinant Human Endostatin Capacity of Key Manufacturers in 2015
Figure China Recombinant Human Endostatin Capacity of Key Manufacturers in 2016
Table China Recombinant Human Endostatin Production of Key Manufacturers (2015 and 2016)
Table China Recombinant Human Endostatin Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Endostatin Production Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Production Share by Manufacturers
Table China Recombinant Human Endostatin Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 China Recombinant Human Endostatin Revenue Share by Manufacturers
Table China Market Recombinant Human Endostatin Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Recombinant Human Endostatin Average Price of Key Manufacturers in 2016
Table Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant Human Endostatin Product Type
Figure Recombinant Human Endostatin Market Share of Top 3 Manufacturers
Figure Recombinant Human Endostatin Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Recombinant Human Endostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Recombinant Human Endostatin Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Recombinant Human Endostatin Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Recombinant Human Endostatin Market Share (2012-2017)
Table Mabtech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mabtech Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Mabtech Recombinant Human Endostatin Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Recombinant Human Endostatin Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Enzon Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Table Genexine Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genexine Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Genexine Recombinant Human Endostatin Market Share (2012-2017)
Table Hetero Drugs Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hetero Drugs Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Hetero Drugs Recombinant Human Endostatin Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Onyx Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Onyx Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Figure Production Revenue Share of Recombinant Human Endostatin by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant Human Endostatin by Type
Table China Recombinant Human Endostatin Price by Type (2012-2017)
Figure China Recombinant Human Endostatin Production Growth by Type (2012-2017)
Table China Recombinant Human Endostatin Consumption by Application (2012-2017)
Table China Recombinant Human Endostatin Consumption Market Share by Application (2012-2017)
Figure China Recombinant Human Endostatin Consumption Market Share by Application in 2016
Table China Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
Figure China Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure China Recombinant Human Endostatin Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Table China Recombinant Human Endostatin Production, Import, Export and Consumption Forecast (2017-2022)
Table China Recombinant Human Endostatin Production Forecast by Type (2017-2022)
Table China Recombinant Human Endostatin Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals
Intas Pharmaceuticals